Reductions in cigarette and cannabis use during a randomized clinical trial for alcohol use disorder
Alcohol and Alcoholism · 2026
DOI: 10.1093/alcalc/agag006 ↗Kurz gefasst
Randomisierte kontrollierte Studie in der Zeitschrift Alcohol and Alcoholism, 2026. Verfasst von Malia A Belnap und 4 weiteren Autor:innen. Beteiligte Einrichtung: Neuroscience Interdepartmental Program, University of California, Los Angeles, 695 Charles E Young Dr S, Los Angeles, CA 90095, United States. Hauptthemen laut MEDLINE: Alcoholism, Cigarette Smoking, Pyridines, Marijuana Use. Die Arbeit nennt 41 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: NICHD NIH HHS, Eunice Kennedy Shriver National Institute of Child Health and Human Development, NIH HHS.
Themen: Sucht und Abhängigkeit
Abstract (Originalsprache)
Objectives
Alcohol, tobacco, and cannabis are the most frequently used psychoactive substances in the United States and are commonly used concurrently. This study analyzed patterns of cigarette and cannabis use during a randomized controlled trial (RCT) for alcohol use disorder (AUD).
Methods
This secondary analysis of a 12-week RCT of ibudilast for AUD (N = 102; 61 M/41F) examined whether cigarette and cannabis use changed over the trial and whether changes in their use were associated with the observed reductions in alcohol consumption.
Results
Individuals significantly reduced their cigarette use over the trial (P = .002). Cannabis use significantly decreased during the early phase of the trial (P = .006) and subsequently increased during the remainder of the trial (P = .03). Changes in cigarette use and cannabis use were not significantly associated with changes in the primary drinking outcome, percent heavy drinking day (Ps ≥ .22). However, changes in the secondary drinking outcome, drinks per drinking day (DPDD), were positively associated with changes in cigarette use across the trial and negatively associated with changes in cannabis use during the early phase of the trial (Ps < .05).
Conclusion
Individuals enrolled in an RCT for AUD were able to reduce their cigarette and cannabis use without being prompted to, and these changes were significantly associated with changes in DPDD. These findings emphasize the importance of evaluating co-occurring substance use in AUD clinical trials, given that significant changes in cigarette and cannabis use behaviors may occur even when not directly targeted.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Neuroscience Interdepartmental Program, University of California, Los Angeles, 695 Charles E Young Dr S, Los Angeles, CA 90095, United States.
- Department of Psychology, University of California, Los Angeles, 1285 Franz Hall, Box 951563, Los Angeles, CA 90095, United States.
- Department of Psychiatry and Biobehavioral Sciences, University of California, Los Angeles, 760 Westwood Blvd, Los Angeles, CA 90095, United States.
- Brain Research Institute, University of California, Los Angeles, 695 Charles E Young Dr S, Los Angeles, CA 90095, United States.
ORCID-Profile: Malia A Belnap, Dylan E Kirsch, Erica N Grodin, Lara A Ray
Förderung
- NICHD NIH HHS
- Eunice Kennedy Shriver National Institute of Child Health and Human Development
- NIH HHS
- NIAAA NIH HHS
- MediciNova, Inc.
- National Institute on Alcohol Abuse and Alcoholism
- National Institutes of Health
Zitieren
APA
Belnap, M. A., McManus, K. R., Kirsch, D. E., Grodin, E. N., & Ray, L. A. (2026). Reductions in cigarette and cannabis use during a randomized clinical trial for alcohol use disorder. Alcohol and Alcoholism. https://doi.org/10.1093/alcalc/agag006
Vancouver
Belnap MA, McManus KR, Kirsch DE, Grodin EN, Ray LA. Reductions in cigarette and cannabis use during a randomized clinical trial for alcohol use disorder. Alcohol and Alcoholism. 2026. doi:10.1093/alcalc/agag006
BibTeX
@article{Belnap2026,
author = {Belnap, Malia A and McManus, Kaitlin R and Kirsch, Dylan E and Grodin, Erica N and Ray, Lara A},
title = {Reductions in cigarette and cannabis use during a randomized clinical trial for alcohol use disorder},
journal = {Alcohol and Alcoholism},
year = {2026},
doi = {10.1093/alcalc/agag006}
}
EUVIMED